Rezafungin Acetate

DRUG2 trials

Sponsors

Mundipharma Research Limited

Conditions

Chronic Pulmonary AspergillosisInvasive Fungal Infections

Phase 1

Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age

TerminatedNCT05534529

Mundipharma Research LimitedInvasive Fungal Infections

Start: 2023-09-13End: 2024-10-14Updated: 2025-04-06

Phase 2

Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options

Active, not recruitingNCT06794554

Mundipharma Research LimitedChronic Pulmonary Aspergillosis

Start: 2025-06-30End: 2026-12-30Target: 60Updated: 2026-05-14